Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers

British Medical Journal

Volumn 313, Issue 7056, 1996, Pages 525-528

  Barrett, P J ^a   Emmins, P D ^a   Clarke, P D ^a   Bradley, D J ^b,c  

^a Med Advsy Serv Travellers Abroad   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Department of Tropical Hygiene ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PROGUANIL;

ANXIETY NEUROSIS; ARTICLE; CHEMOPROPHYLAXIS; CONFUSION; DEPRESSION; FEMALE; GASTROINTESTINAL SYMPTOM; GRAND MAL SEIZURE; HALLUCINATION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PANIC; PERSONALITY DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; VERTIGO;

EID: 0029814571     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7056.525     Document Type: Article

References (3)

1. Bradley DJ, Warhurst DC on behalf of a meeting convened by the Malaria Reference Laboratory. Malaria prophylaxis: guidelines for travellers from Britain. BMJ 1995;310:709-14.
2. Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Sclagenhauf P, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993;341:1299-1303.
3. Council for International Organisations of Medical Sciences. International reporting of adverse drug reactions. CIOMS working group report. Geneva: World Health Organisation, 1987.